Vmbook Online ordering

Bio Rad Laboratories Inc

Sure, here is some general information about Bio-Rad Laboratories, Inc. (BIO)

Bio-Rad Laboratories is a global leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostic markets. The company was founded in 1952 and is headquartered in Hercules, California, USA.

As of March 10th 2023, Bio-Rad Laboratories, Inc. (BIO) stock is trading at approximately $680.52 per share, up $17.02 or 2.55% from the previous close. The stock has a market capitalization of approximately $15.97 billion.

Revenue and Earnings:

In their most recent quarterly earnings report (Q4 2022), Bio-Rad Laboratories, Inc. reported revenue of $1.02 billion, representing a 13.3% increase year over year. Their net income for the quarter was $193.7 million, a 26.6% increase from the same period last year. Adjusted earnings per share were $2.37, representing a 25% increase year over year.

In terms of revenue and earnings growth, Bio-Rad Laboratories, Inc. has consistently demonstrated strong growth over the past few years. In their most recent earnings call, the company attributed their strong performance to increased demand for their life science research and clinical diagnostic products, particularly in the areas of gene editing, immuno-oncology, and droplet PCR. In addition, they have also made significant investments in emerging technologies such as single-cell genomics, synthetic biology, and artificial intelligence.

In conclusion, Bio-Rad Laboratories, Inc. (BIO) is a publicly traded company that has consistently demonstrated strong revenue and earnings growth in recent years. The company is a leader in the life science research and clinical diagnostic markets, with a diverse portfolio of products and a strong history of innovation. As of March 10th 2023, the company's stock is trading at around $680.52, with a market capitalization of approximately $15.97 billion.

I hope this information helps!